Melissa A. Moss

1.7k total citations
51 papers, 1.4k citations indexed

About

Melissa A. Moss is a scholar working on Physiology, Molecular Biology and Biomaterials. According to data from OpenAlex, Melissa A. Moss has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Physiology, 20 papers in Molecular Biology and 10 papers in Biomaterials. Recurrent topics in Melissa A. Moss's work include Alzheimer's disease research and treatments (37 papers), Supramolecular Self-Assembly in Materials (8 papers) and Computational Drug Discovery Methods (6 papers). Melissa A. Moss is often cited by papers focused on Alzheimer's disease research and treatments (37 papers), Supramolecular Self-Assembly in Materials (8 papers) and Computational Drug Discovery Methods (6 papers). Melissa A. Moss collaborates with scholars based in United States, Australia and China. Melissa A. Moss's co-authors include Dana Kim Reed, Michael R. Nichols, Terrone L. Rosenberry, Joseph A. Kotarek, Jan H. Hoh, Christa N. Hestekin, Qian Wang, Kayla M. Pate, Wen-Lang Lin and Rajendrani Mukhopadhyay and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Melissa A. Moss

50 papers receiving 1.4k citations

Peers

Melissa A. Moss
Sean Chia United Kingdom
D. Thanh United States
Jiyong Lee South Korea
Yuxi Lin South Korea
Eric Y. Hayden United States
Melissa A. Moss
Citations per year, relative to Melissa A. Moss Melissa A. Moss (= 1×) peers Marten Beeg

Countries citing papers authored by Melissa A. Moss

Since Specialization
Citations

This map shows the geographic impact of Melissa A. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa A. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa A. Moss more than expected).

Fields of papers citing papers by Melissa A. Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa A. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa A. Moss. The network helps show where Melissa A. Moss may publish in the future.

Co-authorship network of co-authors of Melissa A. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa A. Moss. A scholar is included among the top collaborators of Melissa A. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa A. Moss. Melissa A. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moss, Melissa A., et al.. (2025). Influence of Alzheimer’s associated Aβ oligomers and oxidative stress on blood–brain barrier dysfunction. Tissue Barriers. 14(1). 2553927–2553927. 1 indexed citations
2.
Moss, Melissa A., et al.. (2024). Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization. ChemBioChem. 25(13). e202400060–e202400060. 1 indexed citations
3.
Parker, Patti C., et al.. (2023). Prediction of Pelvic Organ Prolapse Postsurgical Outcome Using Biomaterial-Induced Blood Cytokine Levels: Machine Learning Approach. SHILAP Revista de lepidopterología. 6. e40402–e40402.
4.
Moss, Melissa A., et al.. (2023). Modulating the RAGE‐Induced Inflammatory Response: Peptoids as RAGE Antagonists. ChemBioChem. 24(22). e202300503–e202300503. 8 indexed citations
6.
Moss, Melissa A., et al.. (2019). Obstacles to translating the promise of nanoparticles into viable amyloid disease therapeutics. Physical Biology. 16(2). 21002–21002. 2 indexed citations
7.
Dean, Dexter N., et al.. (2019). Cysteine-rich granulin-3 rapidly promotes amyloid-β fibrils in both redox states. Biochemical Journal. 476(5). 859–873. 8 indexed citations
8.
Sajib, Md Symon Jahan, et al.. (2018). Determining the Potential of Mean Force for Amyloid-β Dimerization: Combining Self-Consistent Field Theory with Molecular Dynamics Simulation. Journal of Chemical Theory and Computation. 14(5). 2696–2704. 23 indexed citations
9.
Pate, Kayla M., Samuel E. Lohse, Mark J. Uline, et al.. (2017). Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer’s disease amyloid-β protein aggregation. Journal of Biological Engineering. 11(1). 5–5. 64 indexed citations
10.
11.
Moss, Melissa A., et al.. (2015). Green and Black Tea Polyphenols Mechanistically Inhibit the Aggregation of Amyloid-β in Alzheimer's Disease. Biophysical Journal. 108(2). 357a–357a. 8 indexed citations
12.
Dean, Dexter N., Amit Kumar, Kayla M. Pate, Melissa A. Moss, & Vijayaraghavan Rangachari. (2015). Self-Propagative Replication of Amyloid-β Oligomers in Alzheimer Disease. Biophysical Journal. 108(2). 66a–66a. 1 indexed citations
13.
Pate, Kayla M., Yi Shen, Anand Viswanath, et al.. (2015). A methacrylate-based polymeric imidazole ligand yields quantum dots with low cytotoxicity and low nonspecific binding. Journal of Colloid and Interface Science. 458. 310–314. 12 indexed citations
14.
Kumar, Amit, Kayla M. Pate, Melissa A. Moss, Dexter N. Dean, & Vijayaraghavan Rangachari. (2014). Self-Propagative Replication of Aβ Oligomers Suggests Potential Transmissibility in Alzheimer Disease. PLoS ONE. 9(11). e111492–e111492. 26 indexed citations
15.
Xie, Fang, et al.. (2011). Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorganic & Medicinal Chemistry. 19(8). 2596–2602. 92 indexed citations
16.
Davis, Timothy J., et al.. (2009). Comparative Study of Inhibition at Multiple Stages of Amyloid-β Self-Assembly Provides Mechanistic Insight. Molecular Pharmacology. 76(2). 405–413. 20 indexed citations
17.
Kotarek, Joseph A. & Melissa A. Moss. (2009). Impact of phospholipid bilayer saturation on amyloid-β protein aggregation intermediate growth: A quartz crystal microbalance analysis. Analytical Biochemistry. 399(1). 30–38. 23 indexed citations
18.
Kotarek, Joseph A., et al.. (2008). Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers. Journal of Neurochemistry. 107(2). 466–477. 56 indexed citations
19.
Moss, Melissa A., et al.. (2007). Soluble aggregates of the amyloid‐β protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. Journal of Neurochemistry. 104(2). 500–513. 36 indexed citations
20.
Nichols, Michael R., et al.. (2004). Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology. Journal of Biological Chemistry. 280(4). 2471–2480. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026